Quick10K

⚲

Ultra Clean

Filings

10-Q	2021-03-26	Filed 2021-05-05
10-K	2020-12-25	Filed 2021-02-23
10-Q	2020-09-25	Filed 2020-11-04
10-Q	2020-06-26	Filed 2020-08-03
10-Q	2020-03-27	Filed 2020-05-06
10-K	2019-12-27	Filed 2020-03-11
10-Q	2019-09-27	Filed 2019-11-05
10-Q	2019-06-28	Filed 2019-08-07
10-Q	2019-03-29	Filed 2019-05-08
10-K	2018-12-28	Filed 2019-03-22
10-Q	2018-09-28	Filed 2018-11-07
10-Q	2018-06-29	Filed 2018-08-08
10-Q	2018-03-30	Filed 2018-05-09
10-K	2017-12-29	Filed 2018-03-14
10-Q	2017-09-29	Filed 2017-11-08
10-Q	2017-06-30	Filed 2017-08-09
10-Q	2017-03-31	Filed 2017-05-10
10-K	2016-12-30	Filed 2017-03-15
10-Q	2016-09-23	Filed 2016-11-01
10-Q	2016-06-24	Filed 2016-08-03
10-Q	2016-03-25	Filed 2016-05-02
10-K	2015-12-25	Filed 2016-03-09
10-Q	2015-09-25	Filed 2015-11-04
10-Q	2015-06-26	Filed 2015-08-05
10-Q	2015-03-27	Filed 2015-05-04
10-K	2014-12-26	Filed 2015-03-11
10-Q	2014-09-26	Filed 2014-11-03
10-Q	2014-06-27	Filed 2014-08-04
10-Q	2014-03-28	Filed 2014-05-05
10-K	2013-12-27	Filed 2014-03-12
10-Q	2013-09-27	Filed 2013-11-01
10-Q	2013-06-28	Filed 2013-08-02
10-Q	2013-03-29	Filed 2013-05-03
10-K	2012-12-28	Filed 2013-03-13
10-Q	2012-09-28	Filed 2012-11-07
10-Q	2012-06-29	Filed 2012-08-07
10-Q	2012-03-30	Filed 2012-05-07
10-K	2011-12-30	Filed 2012-03-21
10-Q	2011-09-30	Filed 2011-11-03
10-Q	2011-07-01	Filed 2011-08-03
10-Q	2011-04-01	Filed 2011-05-06
10-K	2010-12-31	Filed 2011-03-16
10-Q	2010-10-01	Filed 2010-11-09
10-Q	2010-07-02	Filed 2010-08-09
10-Q	2010-04-02	Filed 2010-05-14
10-K	2010-01-01	Filed 2010-03-30

Reports

8-K	2020-10-28
8-K	2020-07-29
8-K	2020-06-02
8-K	2020-04-29
8-K	2020-02-19
8-K	2019-12-17
8-K	2019-10-30
8-K	2019-07-31
8-K	2019-05-30
8-K	2019-05-28
8-K	2019-05-23
8-K	2019-05-02
8-K	2019-03-25
8-K	2019-02-21
8-K	2018-11-06
8-K	2018-10-26
8-K	2018-10-01
8-K	2018-09-05
8-K	2018-08-27
8-K	2018-07-26
8-K	2018-07-24
8-K	2018-06-01
8-K	2018-06-01
8-K	2018-05-15
8-K	2018-04-25
8-K	2018-03-29
8-K	2018-02-21
8-K	2018-02-06
8-K	2018-01-30
8-K	2018-01-29
8-K	2018-01-16

Ultra Clean Financials

UCTT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-07-01	2011-09-30	2011-12-30	2012-03-30	2012-06-29	2012-09-28	2013-03-29	2013-06-28	2013-09-27	2013-12-27	2014-03-28	2014-06-27	2014-09-26	2014-12-26	2015-03-27	2015-06-26	2015-09-25	2015-12-25	2016-03-25	2016-06-24	2016-09-23	2016-12-30	2017-03-31	2017-06-30	2017-09-29	2017-12-29	2018-03-30	2018-06-29	2018-09-28	2018-12-28	2019-03-29	2019-06-28	2019-09-27
Cash	38	38	52	55	51	58	65	71	66	60	74	69	75	79	70	77	60	50	46	44	47	52	55	59	66	68	162	141	160	144	155	168	159
Accounts Receivable	58	48	41	49	42	48	50	47	50	67	72	68	57	62	70	58	58	59	67	73	66	75	95	102	108	90	84	99	95	107	111	98	110
Inventory	70	59	55	61	44	63	51	49	50	64	67	67	55	57	60	65	76	73	82	90	89	104	123	140	165	237	262	229	199	186	180	164	154
PP&E	10	10	10	10	28	32	29	29	41	31	31	32	32	36	40	41	45	46	48	50	52	53	21	23	29	32	37	39	134	143	141	145	144
Assets	194	175	178	193	167	278	270	269	267	293	313	304	284	296	343	342	356	336	346	358	352	381	423	454	501	563	681	644	987	965	1,003	1,009	993
Accounts Payable	49	27	29	39	26	34	35	30	38	54	55	46	42	49	50	46	48	40	53	65	52	71	96	104	131	174	170	114	95	99	99	97	101
Long-Term Debt	23	22	22	21	80	78	71	68	56	55	64	56	48	39	76	74	77	76
Liabilities	90	67	61	70	39	121	114	109	104	121	131	115	101	108	137	133	141	135	148	158	147	165	192	199	224	263	261	204	540	514	550	554	536
Stockholders' Equity	104	108	117	123	128	157	157	160	163	172	182	189	183	189	206	209	215	201	198	200	205	216	232	255	277	300	420	439	435	436	438	439	441


Income Statement ($MM)	2011-07-01	2011-09-30	2011-12-30	2012-03-30	2012-06-29	2012-09-28	2013-03-29	2013-06-28	2013-09-27	2013-12-27	2014-03-28	2014-06-27	2014-09-26	2014-12-26	2015-03-27	2015-06-26	2015-09-25	2015-12-25	2016-03-25	2016-06-24	2016-09-23	2016-12-30	2017-03-31	2017-06-30	2017-09-29	2017-12-29	2018-03-30	2018-06-29	2018-09-28	2018-12-28	2019-03-29	2019-06-28	2019-09-27
Revenue	134	105	87	111	107	101	100	110	107	126	144	133	117	120	125	118	123	103	112	130	146	175	205	228	243	249	315	290	234		260	265	254
Cost of Revenue	115	92	77	95	90	87	87	94	91	105	121	112	107	102	105	99	104	90	98	111	123	145	167	185	200	205	266	244	199		215	217	207
Gross Profit	19	13	10	16	17	14	14	16	16	22	23	21	10	18	20	19	19	13	15	19	23	30	37	43	43	44	49	46	35		45	48	48
R&D	1	1	1	1	1	1	1	1	1	1	2	2	2	2	3	2	2	2	2	2	2	3	3	3	3	3	3	3	3		3	4	4
SG&A	8	7	7	8	9	12	12	12	11	12	12	13	12	12	15	13	14	14	13	13	14	14	15	16	17	19	19	20	31		33	35	36
Tax	2	1	0	2	2	3	0	1	0	1	1	3	1	1	1	1	1	12	1	2	3	3	4	3	4	1	5	4	5		4	5	4
Net Income	7	3	8	5	5	-2	-0	2	2	6	7	11	-5	4	1	2	2	-16	-3	1	3	10	14	20	20	21	25	19	-6		1	-0	1


Cash Flow ($MM)	2011-07-01	2011-09-30	2011-12-30	2012-03-30	2012-06-29	2012-09-28	2013-03-29	2013-06-28	2013-09-27	2013-12-27	2014-03-28	2014-06-27	2014-09-26	2014-12-26	2015-03-27	2015-06-26	2015-09-25	2015-12-25	2016-03-25	2016-06-24	2016-09-23	2016-12-30	2017-03-31	2017-06-30	2017-09-29	2017-12-29	2018-03-30	2018-06-29	2018-09-28	2018-12-28	2019-03-29	2019-06-28	2019-09-27
Cash Operating		2	16	4	16	9	16	9	8	-4	4		17	6	-6	10	0	-4	-0	4	6	8	9	11	17	11	5		27		18	50	21
Cash Investing		-1	-0	-0	-0	-76	-0	-0	-1	-1	-0		-1	-3	-32	-1	-16	-6	-2	-2	-2	-2	-3	-3	-7	-4	-6		-296		-4	-32	-4
Cash Financing		-1	-1	-1	-20	74	-5	-2	-12	-1	10		-10	1	29	-2	-1	-1	-2	-4	-1	-1	-4	-4	-4	-5	95		288		-3	-2	-26